109 related articles for article (PubMed ID: 4617212)
1. Trial of an oral antigen in upper respiratory tract infections in two Bristol schools.
Price HC; Henley G
Practitioner; 1974 Nov; 213(1277):720-6. PubMed ID: 4617212
[No Abstract] [Full Text] [Related]
2. [Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].
Cimadamore N; Agriesti G; Testa A; Borgarello R; Capo G; Crua G
Minerva Pediatr; 1988 Jun; 40(6):355-60. PubMed ID: 3054472
[No Abstract] [Full Text] [Related]
3. Efficacy of a "mixed bacterial vaccine" in prophylaxis of acute respiratory infections: possible role of interferon.
Rytel MW; Ferstenfeld JE; Rose HD; Balay J; Pierce WE; Lynch KL
Am J Epidemiol; 1974 May; 99(5):347-59. PubMed ID: 4151096
[No Abstract] [Full Text] [Related]
4. [Animal experiments with combined local immunization against an influenza virus disease (author's transl)].
Raettig H; Schimmrich B
Z Erkr Atmungsorgane; 1979 May; 153(2):250-3. PubMed ID: 44774
[No Abstract] [Full Text] [Related]
5. [Bacterial allergy in asthmatic syndromes].
Daddi G; Mancini P
Bull Int Union Tuberc; 1976; 51(1 Pt 2):503-6. PubMed ID: 31959
[No Abstract] [Full Text] [Related]
6. Trial of an oral antigen against upper respiratory-tract infection. Results in the second year (1973-74).
Price HC; Henley G
Practitioner; 1976 Mar; 216(1293):341-6. PubMed ID: 772665
[TBL] [Abstract][Full Text] [Related]
7. Hyposensitization with bacterial vaccine in infectious asthma. A double-blind study and a longitudinal study.
Mueller HL; Lanz M
JAMA; 1969 May; 208(8):1379-83. PubMed ID: 4388775
[No Abstract] [Full Text] [Related]
8. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial of bacampicillin in acute bacterial infections.
Ogunyemi O
Clin Ther; 1983; 5(5):472-4. PubMed ID: 6352033
[TBL] [Abstract][Full Text] [Related]
11. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia.
El-Sheikh SM; El-Assouli SM; Mohammed KA; Albar M
Trop Med Int Health; 1998 Mar; 3(3):205-9. PubMed ID: 9593359
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin production in man stimulated by an orally administered bacterial lysate.
Puigdollers JM; Serna GR; Hernandez del Rey I; Barruffet MT; Torroella JJ
Respiration; 1980; 40(3):142-9. PubMed ID: 7003667
[TBL] [Abstract][Full Text] [Related]
13. Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans.
Johnstone DE; Douglas RG; Simon R
Ann Allergy; 1974 Feb; 32(2):70-2. PubMed ID: 4149323
[No Abstract] [Full Text] [Related]
14. Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels.
Rossi GA; Peri C; Raynal ME; Defilippi AC; Risso FM; Schenone G; Pallestrini E; Melioli G
Immunol Lett; 2003 Mar; 86(1):85-91. PubMed ID: 12600750
[TBL] [Abstract][Full Text] [Related]
15. [Experimental sensitizing activity of Neisseria perflava].
Ado AD; Fedoseeva VN; Chitaeva VG; Avdeeva TA
Biull Eksp Biol Med; 1977 Aug; 84(8):191-3. PubMed ID: 71172
[TBL] [Abstract][Full Text] [Related]
16. [Significance of precipitating antibodies to bacterial antigens in the blood in chronic pneumonia].
Porubinovskaia NM; Romanova RIu; Zhukovskiĭ AM; Klimanskaia EV; Monakhova SI
Probl Tuberk; 1980 Apr; (4):43-6. PubMed ID: 6992138
[No Abstract] [Full Text] [Related]
17. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
Jacobs E; Dalhoff A; Korfmann G
Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
Melo-Cristino J; Fernandes ML; Serrano N;
Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
[TBL] [Abstract][Full Text] [Related]
19. [Colonization (infection) of the respiratory tract in outpatients in 2000-2005 years].
Kaczała M; Kopron K; Gmyrek J; Giedrys-Kalemba S
Pol Merkur Lekarski; 2008 Mar; 24(141):195-201. PubMed ID: 18634283
[TBL] [Abstract][Full Text] [Related]
20. Activity of oral antibiotics against respiratory tract pathogens in Spain.
Calvo A; Amores R; Valero E; Fuentes F; Gómez-Lus ML; Prieto J;
Rev Esp Quimioter; 2003 Dec; 16(4):436-43. PubMed ID: 14961138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
